首页> 外文期刊>Investigative ophthalmology & visual science >Antimicrobial Efficacy of New Investigational Multipurpose Disinfecting Solution and Comparison to Commercially Available Multipurpose Disinfecting Solutions
【24h】

Antimicrobial Efficacy of New Investigational Multipurpose Disinfecting Solution and Comparison to Commercially Available Multipurpose Disinfecting Solutions

机译:新型研究型多功能消毒液的抗菌功效以及与市售多功能消毒液的比较

获取原文
           

摘要

Purpose: To evaluate antimicrobial efficacy of investigational multipurpose formulation against bacteria, fungi and Acanthamoeba spp. and compare it to commercially available multipurpose disinfecting solutions (MPS). Study was done according to ISO 14729:2001/A.2010 standard. Methods: The multipurpose disinfecting solutions studied were - Investigational MPS-1: polyhexamethylene biguanide (PHMB) + poloxamer (PLX) and currently marketed Japan products MPS-2: polyquaternium (PQ1) + tetronic 1304, MPS-3: PHMB + poloxamine (PLA) and MPS-4: PHMB +PLX. Test organisms were: Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 9027), Serratia marcescens (ATCC 13880), Candida albicans (ATCC 10231), Fusarium solani (ATCC 36031) and Gram-negative clinical isolates. Test solutions were evaluated at the minimum recommended disinfection time of 4 hours. Disinfectant efficacy of MPS was also evaluated against Acanthamoeba trophozoites. Results: After 4 hours exposure, Investigational MPS-1 and MPS-3 showed 3 log kill of ISO bacteria and fungi. MPS-2 and MPS-4 failed to meet stand-alone criteria for ISO bacteria and fungi. MPS-1, MPS-3 and MPS-4 showed 3 log kill against clinical isolates, while MPS-2 showed 1 log kill. MPS-1 and MPS-3 achieved 3 log reduction for Acanthamoeba trophozoites, while MPS-4 achieved 2 log reduction and MPS-2 achieved 1 log reduction. Conclusions: New Investigational MPS-1 exhibited broad antimicrobial activity against ISO panel organisms and showed additional robustness against clinical isolates and Acanthamoeba trophozoites. MPS-1 showed similar activity as MPS-3, while MPS-2 and MPS-4 failed to meet stand-alone criteria against ISO organisms and clinical isolates.
机译:目的:评估研究性多功能制剂对细菌,真菌和棘阿米巴属菌的抗菌功效。并将其与市售的多功能消毒液(MPS)进行比较。根据ISO 14729:2001 / A.2010标准进行了研究。方法:研究的多功能消毒溶液为-研究性MPS-1:聚六亚甲基双胍(PHMB)+泊洛沙姆(PLX),以及目前在日本销售的产品MPS-2:聚季铵盐(PQ1)+ tetronic 1304,MPS-3:PHMB +泊洛沙明(PLA) )和MPS-4:PHMB + PLX。测试生物为:金黄色葡萄球菌(ATCC 6538),铜绿假单胞菌(ATCC 9027),粘质沙雷氏菌(ATCC 13880),白色念珠菌(ATCC 10231),茄枯萎病菌(ATCC 36031)和革兰氏阴性临床分离株。在建议的最少4小时消毒时间下对测试溶液进行评估。还评估了MPS对棘阿米巴滋养体的消毒效果。结果:暴露4小时后,研究性MPS-1和MPS-3显示ISO细菌和真菌的对数杀伤> 3。 MPS-2和MPS-4无法满足ISO细菌和真菌的独立标准。 MPS-1,MPS-3和MPS-4对临床分离株的杀伤力> 3,而MPS-2对临床分离株的杀伤力<1。棘阿米巴滋养体的MPS-1和MPS-3减少了> 3对数,而MPS-4减少了<2对数,MPS-2减少了<1对数。结论:新的研究性MPS-1对ISO面板微生物表现出广泛的抗菌活性,并且对临床分离株和棘阿米巴滋养体具有更强的抵抗力。 MPS-1显示出与MPS-3类似的活性,而MPS-2和MPS-4未能满足针对ISO生物体和临床分离株的独立标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号